| mRNA | Messenger ribonucleic acid |
| pDNA | Plasmid deoxyribonucleic acid |
| siRNA | Small interfering ribonucleic acid |
| DMG-PEG | 1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2k |
| DSPE-PEG-N3 | 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N [azido (polyethylene glycol)-2k] |
| (SPAAC) | Strain-promoted azide-alkyne cycloaddition |
| DBCO | Dibenzocyclooctyne |
| LNP | Lipid nanoparticle |
| FDA | Food and Drug Administration |
| COVID-19 | Coronavirus disease 2019 |
| pHPMA | Poly(N-(2-hydroxypropyl)methacrylamide) |
| pOx | Poly(2-oxazoline) |
| apoE | Apolipoprotein E |
| LAF | Lipo-amino fatty acid |
| LAF-XP | Lipo-amino fatty acid–xenopeptide |
| SPPS | Solid-phase-assisted peptide synthesis |
| Stp | Succinoyl tetraethylene pentamine |
| EGFR | Epidermal growth factor receptor |
| HEPES | 4-(2-Hydroxyethyl)-1-piperazineethansulfonic acid |
| HBG | HEPES-buffered glucose |
| PBS | Phosphate-buffered saline |
| DLS | Dynamic light scattering |
| N2A | Neuro-2a cell line |
| HEPG2 | Human hepatocellular carcinoma cell line |
| HUH7 | Human hepatoma cell line |
| PDI | Polydispersity index |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| HPLC | High-performance liquid chromatography |
| MALDI-TOF-MS | Matrix-assisted laser desorption/ionization–time of flight–mass spectrometry |
| EtBr | Ethidium bromide |
| FGG | Fibrinogen |
| Csf1r | Colony stimulating factor 1 receptor |
| PEI | Polyethylenimine |
| NTA | Nanoparticle tracking analysis |